Search results
Results from the Health.Zone Content Network
The COVID-19 vaccination program in the Philippines was a mass immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the pandemic in the country. The vaccination program was initiated by the Duterte administration on March 1, 2021, a ...
An International Certificate of Vaccination or Revaccination Against Yellow Fever, issued in the Soviet Union in 1985. The International Certificate of Inoculation and Vaccination was established by the International Sanitary Convention for Aerial Navigation (1933) in The Hague, which came into force on 1 August 1935 and was amended in 1944. [3]
A COVID-19 vaccine card is a record often given to those who have received a COVID-19 vaccine showing information such as the date (s) one has received the shot (s) and the brand of vaccine one has received, sometimes including the lot number. The card also contains information identifying the recipient and the location where the shot was given.
During the COVID-19 pandemic, several COVID-19 vaccines were developed, and in December 2020 the first vaccination campaign was planned. Anticipating the vaccine, on 23 November 2020, Qantas announced that the company would ask for proof of COVID-19 vaccination from international travellers. According to Alan Joyce, the firm's CEO, a ...
The FDA has approved three COVID-19 vaccine brands in the United States: Pfizer-BioNTech, Moderna, and J&J vaccines. U.S. adults have received more than 284 million doses of the Pfizer vaccine ...
COVID Vaccines Compared. There are four COVID-19 vaccines approved for use in the U.S. The Pfizer, Moderna, Novavax, and Johnson & Johnson vaccines are all highly effective in protecting you from ...
The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, [2] [32] is an mRNA-based COVID-19 vaccine developed by the German biotechnology company BioNTech. For its development, BioNTech collaborated with the American company Pfizer to carry out clinical trials, logistics, and manufacturing. [44] [45] It is authorized for use ...
In February 2021, Novavax partnered with Takeda to manufacture the vaccine in Japan, where its COVID‑19 vaccine candidate is known as TAK-019. [54] Novavax signed an agreement with Serum Institute of India for mass scale production for developing and low-income countries. [55]